Supplements Last reviewed: June 25, 2026

Does elderberry prevent or shorten colds?

Moderate Evidence
Confidence Score 52%
โš–๏ธ

IT DEPENDS

Moderate evidence suggests elderberry supplementation may reduce the duration and severity of upper respiratory infections, particularly colds, by 1-2 days. Evidence for prevention is weaker. Most positive trials are small, and a large 2021 RCT showed no significant benefit.

The Verdict

Moderate evidence suggests elderberry supplementation may reduce the duration and severity of upper respiratory infections, particularly colds, by 1-2 days. Evidence for prevention is weaker. Most positive trials are small, and a large 2021 RCT showed no significant benefit.

What the Evidence Shows

Elderberry (Sambucus nigra) extracts contain anthocyanins and flavonoids that demonstrate antiviral activity in vitro, including inhibition of viral hemagglutinin and stimulation of cytokine production. A 2019 meta-analysis of 4 RCTs (n=180) found elderberry supplementation substantially reduced upper respiratory symptom duration (mean difference -1.8 days) and severity. Individual positive trials include a 2004 RCT showing elderberry syrup reduced influenza duration by 4 days and a 2016 trial in air travelers showing reduced cold duration and severity. However, these trials were small (n=60-312) and some were manufacturer-funded. A much larger 2021 RCT (n=87) by Macknin et al. in adults and children with influenza found no significant difference in symptom duration between elderberry extract and placebo, challenging earlier positive findings. The discrepancy may reflect publication bias in smaller trials or differences in elderberry preparation and dosing. The evidence is stronger for treatment (reducing duration once sick) than prevention. Elderberry appears safe for short-term use, though raw berries contain cyanogenic glycosides requiring cooking.

Evidence Quality

2

Meta-Analyses

5

RCTs

4

Observational

Important Caveats

  • โš ๏ธ Most positive studies are small (n<100) and some are industry-funded
  • โš ๏ธ A larger 2021 RCT found no significant benefit over placebo
  • โš ๏ธ Evidence for prevention is weaker than for treatment of existing symptoms
  • โš ๏ธ Standardization of elderberry extracts varies significantly between products

Population Studied

Healthy adults and air travelers with upper respiratory infections; adults and children with confirmed influenza; ages 5-65

Dosage

Most studies used 600-900 mg elderberry extract daily or 15 ml elderberry syrup 4 times daily during illness

Duration

Treatment studies lasted 3-5 days during acute illness; prevention studies lasted 10-17 days during travel periods

Supporting Studies (2)

Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: a meta-analysis of randomized, controlled clinical trials

Meta-Analysis

Hawkins J, Baker C, Cherry L, Dunne E. ยท Complementary Therapies in Medicine (2019)

Meta-analysis of 4 RCTs found elderberry supplementation substantially reduced upper respiratory symptom duration and severity, with greater effects for influenza-like symptoms than common cold symptoms.

View paper (DOI) โ†’

Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections

RCT

Zakay-Rones Z, Thom E, Wollan T, Wadstein J. ยท Journal of International Medical Research (2004)

Elderberry syrup (15 ml 4x daily) reduced influenza symptom duration by an average of 4 days compared to placebo, with symptom improvement beginning within 2-3 days of treatment onset.

View paper (DOI) โ†’

Contradicting Studies (1)

Effect of elderberry extract on symptoms of influenza: a randomized double-blind placebo-controlled clinical trial

RCT

Macknin M, Wolski KE, Negrey J, Mace S. ยท Journal of General Internal Medicine (2021)

In 87 influenza patients (adults and children), elderberry extract showed no significant difference from placebo in time to symptom resolution, total symptom severity, or fever duration over 5 days of treatment.

Why this disagrees:

This larger, more rigorously designed trial challenges the positive findings from smaller earlier studies, suggesting that publication bias or methodological limitations may have inflated previous estimates of elderberry's efficacy.

View paper (DOI) โ†’
Share:
Was this helpful?

Related Claims